University of Barcelona's researchers led by Professor Carles Enrich, from the Department of Cell Biology, Immunology and Neurosciences of the Faculty of Medicine at the University of Barcelona (UB) and CELLEX Biomedical ...
May 22, 2014
1
0
Heart disease patients taking PCSK9 inhibitors to achieve very low levels of cholesterol do not experience an increase in adverse events, including memory impairment or nervous system disorders, but may have an increased ...
Jan 30, 2017
0
0
The general perception supports the mantra of "lower is better" for low-density lipoprotein cholesterol (LDL-C) levels in cardiovascular disease. However, during the acute stage of ischemic stroke, it is unclear how to interpret ...
Jun 27, 2023
0
2
A study that used two-dimensional echocardiography to closely examine the hearts of 100 children and teens found physical and functional signs of future heart problems already developing in obese children.
Oct 8, 2014
0
0
A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different ...
May 29, 2024
0
0
Genetically-predicted systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C) increase the risk for coronary heart disease (CHD), independent of age, according to a study published online Dec. 20 in ...
Dec 21, 2023
0
0
The drug alirocumab (trade name: Praluent) has been approved since September 2015 for adults with hypercholesterolaemia or mixed dyslipidaemia whose cholesterol levels are not adequately lowered by diet and other drugs. It ...
Feb 17, 2016
0
0
Despite recommendations, less than 45 percent of adults younger than 40 years with an elevated low-density lipoprotein cholesterol (LDL-C) level of 190 mg/dL or greater receive a prescription for a statin, according to a ...
Jan 4, 2017
0
1
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Oct 4, 2017
0
0
A study in Japanese patients with diabetic retinopathy has questioned the benefit of treat-to-target intensive versus standard statin therapy. The late-breaking results from the EMPATHY trial are presented today in a Hot ...
Aug 29, 2017
0
0
